Antonio Passaro: I had the opportunity to participate in the Immuno Oncology South Africa
Antonio Passaro, Medical oncologist at the European Institute of Oncology in Milan, shared a post on LinkedIn:
“On February 21-22, I had the opportunity to participate in the Immuno Oncology South Africa (IOSA) meeting in Johannesburg. This event provided a comprehensive overview of immuno-oncology IO advancements, with in-depth discussions on the latest treatment options for renal cell carcinoma, breast cancer, melanoma and lung cancer.
I had the pleasure of discussing the evolution of treatments for early-stage NSCLC, focusing on the latest advancements in neoadjuvant, adjuvant, and perioperative therapies.
A warm thank you to the organizers for the invitation and for the opportunity to contribute to such an enriching event.
Looking forward to continuing the conversation and advancing the field of immuno-oncology together!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023